APA

Shapiro A. D., Di Paola J., Cohen A., Pasi K. J., Heisel M. A., Blanchette V. S., Abshire T. C., Hoots W. K., Lusher J. M., Negrier C., Rothschild C. & Roth D. A. (20050215). The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. : Blood.

Chicago

Shapiro Amy D, Di Paola Jorge, Cohen Alice, Pasi K John, Heisel Margaret A, Blanchette Victor S, Abshire Thomas C, Hoots W Keith, Lusher Jeanne M, Negrier Claude, Rothschild Chantal and Roth David A. 20050215. The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. : Blood.

Harvard

Shapiro A. D., Di Paola J., Cohen A., Pasi K. J., Heisel M. A., Blanchette V. S., Abshire T. C., Hoots W. K., Lusher J. M., Negrier C., Rothschild C. and Roth D. A. (20050215). The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. : Blood.

MLA

Shapiro Amy D, Di Paola Jorge, Cohen Alice, Pasi K John, Heisel Margaret A, Blanchette Victor S, Abshire Thomas C, Hoots W Keith, Lusher Jeanne M, Negrier Claude, Rothschild Chantal and Roth David A. The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. : Blood. 20050215.